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o r i g i n a l a r t i c l e
A Multicenter Intervention to Prevent
Catheter-Associated Bloodstream Infections
David K. Warren, MD, MPH; Sara E. Cosgrove, MD; Daniel J. Diekema, MD; Gianna Zuccotti, MD;
Michael W. Climo, MD; Maureen K. Bolon, MD; Jerome I. Tokars, MD, MPH; Gary A. Noskin, MD;
Edward S. Wong, MD; Kent A. Sepkowitz, MD; Loreen A. Herwaldt, MD; Trish M. Perl, MD, MSc;
Steven L. Solomon, MD; Victoria J. Fraser, MD; for the Prevention Epicenter Program
background. Education-based interventions can reduce the incidence of catheter-associated bloodstream infection. The generalizability
of findings from single-center studies is limited.
objective. To assess the effect of a multicenter intervention to prevent catheter-associated bloodstream infections.
design. An observational study with a planned intervention.
setting. Twelve intensive care units and 1 bone marrow transplantation unit at 6 academic medical centers.
patients. Patients admitted during the study period.
intervention. Updates of written policies, distribution of a 9-page self-study module with accompanying pretest and posttest, didactic
lectures, and incorporation into practice of evidence-based guidelines regarding central venous catheter (CVC) insertion and care.
measurements. Standard data collection tools and definitions were used to measure the process of care (ie, the proportion of non-
tunneled catheters inserted into the femoral vein and the condition of the CVC insertion site dressing for both tunneled and nontunneled
catheters) and the incidence of catheter-associated bloodstream infection.
results. Between the preintervention period and the postintervention period, the percentage of CVCs inserted into the femoral vein
decreased from 12.9% to 9.4% (relative ratio, 0.73; 95% confidence interval [CI], 0.61-0.88); the total proportion of catheter insertion site
dressings properly dated increased from 26.6% to 34.4% (relative ratio, 1.29; 95% CI, 1.17-1.42), and the overall rate of catheter-associated
bloodstream infections decreased from 11.2 to 8.9 infections per 1,000 catheter-days (relative rate, 0.79; 95% CI, 0.67-0.93). The effect of
the intervention varied among individual units.
conclusions. An education-based intervention that uses evidence-based practices can be successfully implemented in a diverse group
of medical and surgical units and reduce catheter-associated bloodstream infection rates.
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Central venous catheters (CVCs) are indispensable in the care
of critically ill patients. However, their use is not without risk.
Catheter-associated bloodstream infections (CA-BSIs) are
common healthcare-associated infections in intensive care
unit (ICU) patients1 and have been estimated to occur in 3%-
7% of all patients with CVCs.2 Nontunneled CVCs are the
most frequently used devices in ICUs. Despite being used for
relatively brief periods, these catheters are associated with a
higher rate of infection than are tunneled catheters or totally
implanted ports, which are used for relatively longer periods.3
Use of newer devices such as antimicrobial- and antiseptic-
impregnated CVCs reduces the risk of CA-BSI4-7; however,
use of these devices may not be more effective than ensuring
use of appropriate methods for insertion, use, and care of
CVCs. Practices that reduce the risk of CA-BSIs include the
following: (1) use of maximal barrier precautions during CVC
insertion (ie, a surgical mask, sterile gown, sterile gloves, and
large sterile drapes),8,9 (2) placement of the catheter in the
subclavian vein rather than the internal jugular or femoral
vein,10,11 (3) changing catheters only when necessary,12,13 and
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(4) changing dressings on CVC exit sites when they be-
come nonocclusive, soiled, or bloody.14 These practices have
been incorporated into national guidelines.15,16 Currently, the
Healthcare Infection Control Practices Advisory Committee
(HICPAC) of the Centers for Disease Control and Prevention
(CDC) recommends that hospitals implement comprehensive
educational programs that teach proper CVC insertion and
maintenance techniques.
Several studies have examined education-based interven-
tions to reduce the incidence of CA-BSIs in single institu-
tions17-22 and within a single city.23 These interventions have
used didactic training sessions17,21,23 or a combination of both
didactic and hands-on training.20,19 The interventions have
educated various groups of healthcare workers, including res-
ident physicians and medical students,20 physicians-in-train-
ing and nursing staff,17,19,21 intensivists and nurses,22 and nurses
alone.23 Six of these studies reported a 28%-72% decrease in
the incidence of CA-BSI in the postintervention period.18-22
These studies demonstrate that education-based interven-
tions can help prevent CA-BSIs. However, questions remain
regarding the generalizability of these interventions to mul-
tiple healthcare systems, because the studies were conducted
either at single centers or within a single city. Thus, an ef-
fective intervention that could be implemented broadly would
have a clear public health benefit. The purpose of this study
was to implement a multifaceted, education-based interven-
tion in ICUs at 6 academic medical centers and to assess the
effect of the intervention on processes of CVC care and the




The intervention took place in 13 ICUs at 6 academic tertiary
care hospitals (mean size, 775 beds; range, 427-1,385 beds)
participating in the CDC Prevention Epicenter Program.
Adult ICUs and select bone marrow transplantation units
were eligible for study; 2 or 3 units participated at each hos-
pital. Units were selected by local investigators if they met
the following criteria: (1) the incidence of CA-BSI had been
at or above the mean unit-specific rate reported in the Na-
tional Nosocomial Infection Surveillance System for at least
12 months, (2) the incidence of CVC utilization was stable,
and (3) the unit leadership (ie, the unit medical and nursing
directors) were willing to participate in the study. For pur-
poses of the study, units were defined as being primarily
medical (ie, medical ICU, coronary care unit, or bone marrow
transplantation unit), surgical (ie, surgical ICU or cardio-
thoracic ICU), or mixed (ie, medical-surgical ICU or neu-
rology-neurosurgical ICU).
Description of the Intervention
The intervention consisted of several elements that were im-
plemented over a 3-month period in each unit. The first
element consisted of reviewing and updating hospital and/or
unit policies and procedures concerning the insertion, care,
and use of nontunneled CVCs. Local investigators used a
standardized data collection tool to survey existing policies
and procedures in each unit and compared these policies with
the CDC/HICPAC recommendations.16 For those units that
either did not have a defined policy or had a policy not
consistent with current CDC guidelines, the individual in-
vestigator worked with the appropriate local staff to create
or update the policy.
The second element of the invention consisted of educating
staff. This was accomplished by 3 methods. Didactic lectures
were given for physicians and nursing staff; investigators used
a standardized slide show for these presentations. A stan-
dardized, 9-page, self-study module with accompanying 24-
question pretest and posttest (which were identical) was dis-
tributed to physicians who inserted nontunneled catheters
and to nursing staff in each unit. The self-study module, based
on a previously studied module,22 provided information on
risk factors for CA-BSIs, and proper practices for the inser-
tion, care, and use of CVCs were updated to reflect CDC/
HICPAC recommendations published in 2002. Fact sheets
and posters highlighting proper techniques for CVC insertion
and care were placed in the units in places that staff were
likely to see and read them. The primary messages of the
intervention material were as follows: (1) the subclavian vein
is the preferred insertion site for a nontunneled CVC, and
the femoral vein is the least desirable site; (2) catheters should
be inserted using maximal sterile barrier precautions; (3)
catheter insertion site dressings should be kept clean, dry,
and intact; and (4) catheter dressings should be properly
dated, to ensure regular dressing changes.
Any other new interventions that were performed at in-
dividual Prevention Epicenter Program sites and that might
affect the outcome of this study (ie, bundling of supplies and/
or procedure carts or hands-on training of staff) were mon-
itored by individual investigators at their sites and recorded.
Of note, one ICU instituted an education-based intervention
at the start of the preintervention period.24 The overall cath-
eter-associated infection rate was calculated both with and
without this unit’s data.
Collection of Data
Baseline data collection to identify ICU-acquired, catheter-
related bloodstream infections was initiated in January 2002,
which was 5-7 months before the intervention was begun,
and it was continued for 15-18 months after the intervention
in each study unit (ie, until December 2003). Study personnel
collected data on the total number of patient-days and the
total number of nontunneled catheter-days per month per
ICU. To determine whether the intervention changed the pro-
cesses of CVC insertion and care within the study units, once
per week (Monday through Friday), study personnel con-
ducted unannounced point-prevalence surveys of CVCs pres-
664 infection control and hospital epidemiology july 2006, vol. 27, no. 7
























A Medical Yes Yes Yes Yes Yes No 2.0
B Surgical Yes Yes Yes No Yes No 4.2
C Medical Yes Yes Yes Yes No No 3.6
D Medical Yes Yes Yes Yes No No 3.8
E Medical Yes Yes Yes Yes Yes Yes 4.2
F Mixed Yes Yes Yes Yes No No 4.0
G Mixed Yes Yes No Yes Yes No 3.8
H Surgical Yes Yes Yes Yes No No 4.0
I Surgical Yes Yes No Yes Yes No 3.7
J Surgical Yes Yes Yes Yes Yes No 3.6
K Medical Yes Yes Yes No Yes No 4.6
L Surgical Yes Yes Yes No No No 3.8
M Surgical Yes Yes Yes Yes Yes No 3.6
note. CVC, central venous catheter.
a Scale: 1 indicates “strongly disagree” and 5 indicates “strongly agree” with statement.
ent in patients in the unit at that time. The anatomic location
of nontunneled catheters (ie, in the femoral, subclavian, or
internal jugular veins) and the condition of catheter insertion
site dressings for both tunneled and nontunneled catheters
(ie, whether the dressing was visibly bloody and whether the
dressing was dated) were noted on a standard data collection
tool. For the 5 units that used antimicrobial- or antiseptic-
coated catheters, the number of these catheters used during
the study period was noted. Data on the anatomical sites of
CVCs were collected through March 2003 for all study units.
We reviewed all blood cultures that yielded a pathogen for
which the blood samples were obtained in the study units or
within 48 hours after discharge from the unit. A bloodstream
infection was considered to be unit-related if it occurred 48
hours after admission to or 48 hours after discharge from
the study unit. CA-BSI was defined according to published
criteria,25 with one exception: because the intervention was
focused on the insertion and care of nontunneled CVCs,
patients with totally implantable ports or hemodialysis cath-
eters only were excluded from the analysis their catheter-days
were not added to the monthly denominator data, since these
types of catheters have infection risks and care processes that
are distinct from other central venous access devices.
To assess the extent to which the intervention was imple-
mented in each unit, study personnel collected data on the
total number of eligible unit nurses and physicians who re-
ceived the self-study module during the intervention period
and whether the various components of the intervention (e.g.,
posters and didactic sessions) were used in each unit. At the
end of the intervention period, before the outcome data were
analyzed, investigators at each hospital filled out a question-
naire to rate the degree of support for the intervention given
by the unit’s medical director, nursing director, nursing staff,
and physician staff. The answers to the questions were pre-
sented as a Likert scale (ie, 1 p strongly disagree; 5 p
strongly agree).
Analysis of Data
Data were analyzed using SPSS for Windows, version 11.0
(SPSS). The incidence rate of CA-BSIs per 1,000 catheter-
days was calculated, and a relative rate of CA-BSIs in the
postintervention period (including the 0-3–month interven-
tion period) compared with the preintervention period was
determined, with 95% confidence intervals (CIs), for each
unit individually and in aggregate.26 The relative ratio of hav-
ing a femoral catheter and a bloody or undated dressing
during the preintervention and the postintervention periods
was calculated for each unit and in aggregate; the x2 test was
used to compare the proportions. A 2-tailed P vlaue of less
than .05 was considered statistically significant.
Approvals and Informed Consent
The institutional review boards at each study site and at the
CDC approved this study. The review boards concurred that
written consent was not required from each patient in the
study units, because the measures used were considered stan-
dard-of-care. One review board required that the investigators
mail the self-study modules and the pretest and posttest to
the nurses and residents, because they felt that staff could be
intimidated into participating by supervisors or investigators
if the tests were done in a group. The CDC, which sponsored
the study, was involved in the study design and in the writing
of the report for publication.



































A Medical 45/120 (37.5) 35/183 (19.1) 0.51 (0.35-0.74)c 26/117 (22.2) 21/175 (12) 0.54 (0.32-0.91)c 35/117 (29.9) 45/175 (25.7) 0.86 (0.59-1.25)
B Surgical 4/50 (8.0) 4/291 (1.4) 0.17 (0.04-0.66)c 22/50 (44.0) 93/298 (31.2) 0.71 (0.50-1.01) 11/50 (22.0) 100/298 (33.6) 1.53 (0.88-2.63)
C Medical 23/93 (24.7) 21/89 (23.6) 0.95 (0.57-1.60) 13/108 (12.0) 11/126 (8.7) 0.73 (0.34-1.55) 5/108 (4.6) 29/126 (23.0) 4.97 (1.99-12.4)c
D Medical 16/58 (27.6) 15/63 (23.8) 0.86 (0.47-1.58) 11/63 (17.5) 8/84 (9.5) 0.55 (0.23-1.28) 0/63 (0) 14/84 (16.7) Undefined
E Medical 17/204 (8.3) 35/294 (11.9) 1.43 (0.82-2.48) 100/206 (48.5) 102/286 (35.7) 0.73 (0.60-0.91)c 118/206 (57.3) 162/286 (56.6) 0.99 (0.85-1.16)
F Mixed 2/47 (4.3) 2/133 (1.5) 0.35 (0.05-2.44) 12/49 (24.5) 44/142 (31.0) 1.27 (0.73-2.19) 17/49 (34.7) 59/142 (41.5) 1.20 (0.78-1.84)
G Mixed 38/103 (36.9) 31/181 (17.1) 0.46 (0.31-0.70)c 6/133 (4.5) 4/230 (1.7) 0.39 (0.11-1.34) 133/133 (100) 230/230 (100) Undefined
H Surgical 3/40 (7.5) 3/116 (2.6) 0.34 (0.07-1.64) 13/50 (26.0) 43/134 (32.1) 1.23 (0.73-2.09) 21/50 (42.0) 53/134 (39.6) 0.94 (0.64-1.39)
I Surgical 0/43 (0) 3/140 (2.1) Undefined 7/236 (3.0) 23/488 (4.7) 1.59 (0.69-3.65) 0/236 (0) 0/488 (0) Undefined
J Surgical 1/95 (1.1) 8/190 (4.2) 4.00 (0.51-31.52) 19/94 (20.2) 47/194 (24.2) 1.20 (0.75-1.92) 13/94 (13.8) 23/194 (11.9) 0.86 (0.45-1.62)
K Medical 13/57 (22.8) 76/421 (18.1) 0.79 (0.47-1.33) 15/60 (25.0) 100/432 (23.1) 0.93 (0.58-1.48) 25/60 (41.7) 268/432 (62.0) 1.49 (1.09-2.03)c
L Surgical 16/281 (5.7) 9/246 (3.7) 0.64 (0.29-1.43) 32/273 (11.7) 28/238 (11.8) 1.00 (0.62-1.62) 9/273 (3.3) 59/238 (27.8) 7.52 (3.81-14.8)c
M Surgical 0/191 (0) 14/363 (3.9) Undefined 125/192 (65.1) 183/363 (50.4) 0.77 (0.67-0.90)c 46/192 (24.0) 52/363 (14.3) 0.60 (0.42-0.85)c
All units … 178/1382 (12.9) 256/2710 (9.4) 0.73 (0.61-0.88)c 401/1631 (24.6) 707/3190 (22.2) 0.90 (0.81-1.00) 434/1631 (26.6) 1094/3190 (34.3) 1.29 (1.17-1.42)c
note. CI, confidence interval.
a For nontunneled CVCs only.
b Postintervention data for this table are from the period through March 2003 only (see Methods).
c Statistically significant.
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table 3. Number and Rate of Catheter-Associated Bloodstream Infections (CA-BSIs)














A Medical 24 (21.4) 31 (9.7) 0.45 (0.26-0.81)a
B Medical 32 (19.2) 42 (9.7) 0.50 (0.31-0.83)a
C Medical 11 (12.6) 28 (10.8) 0.86 (0.41-1.90)
D Medical 8 (15.3) 12 (6.3) 0.41 (0.16-1.17)
E Medical 21 (16.0) 86 (18.5) 1.16 (0.71-1.96)
F Mixed 16 (13.0) 23 (5.5) 0.42 (0.21-0.86)a
G Mixed 20 (11.4) 31 (7.8) 0.69 (0.38-1.28)
H Surgical 13 (9.7) 36 (8.1) 0.83 (0.43-1.71)
I Surgical 26 (6.4) 65 (7.2) 1.13 (0.71-1.85)
J Surgical 5 (5.5) 37 (11.5) 2.10 (0.82-6.86)
K Surgical 28 (12.8) 70 (12.0) 0.93 (0.59-1.50)
L Surgical 13 (6.1) 21 (4.1) 0.68 (0.32-1.47)
M Surgical 12 (9.5) 26 (5.3) 0.56 (0.27-1.21)
All units … 229 (11.2) 508 (8.9) 0.79 (0.67-0.93)a
note. CI, confidence interval; CVC, central venous catheter.
a Statistically significant
results
Baseline Characteristics of Study Units
The 13 study units had a mean of 16.7 beds (range, 12-31
beds). Their types were as follows: 4 (30.8%) were medical
ICUs, 3 (23.1%) were surgical ICUs, 1 (7.7%) was a coronary
care ICU, 2 (15.4%) were cardiothoracic surgical ICUs, 1
(7.7%) was a neurological-neurosurgical ICU, 1 (7.7%) was
a medical-surgical ICU, and 1 (7.7%) was a bone marrow–
stem cell transplantation unit. We evaluated a total of 77,728
catheter-days (20,381 in the preintervention period and
57,347 in the postintervention period) during 118,753 pa-
tient-days (30,191 in the preintervention period and 88,562
in the postintervention period). The overall proportion of
CVC-days to patient-days was slightly higher in the prein-
tervention period than in the postintervention period (0.68
vs. 0.65 catheter-days per patient-day; ).P ! .001
Implementation of the Intervention Within Individual
Study Units
The implementation of key components of the intervention
is noted in Table 1. Eight (62%) of 13 units bundled supplies
for maximal sterile barrier precautions with catheter inser-
tion kits, and 1 unit conducted hands-on training to teach
house staff how to insert catheters using teaching manne-
quins. A total of 414 (75%) of 549 eligible nurses (range,
35%-100% per unit) and 276 (67%) of 410 eligible physicians
(range, 17%-86% per unit) received the module. When asked
whether the unit staff supported the intervention, local in-
vestigators gave answers that varied considerably by unit
(mean Likert scale rating, 3.7; range, 2.0-4.6) and by staff
type (mean rating: nurse managers, 4.1; medical directors,
3.7; nursing staff, 3.8; resident physicians, 3.7; and attending
physicians, 3.4).
Effect of the Intervention on CVC Care and CA-BSI Rates
During the study period, 4,821 CVC insertion sites were ob-
served (729 tunneled and 4,092 nontunneled catheter sites).
Of the 4,092 nontunneled catheters, 434 (10.6%) were in-
serted in the femoral vein. The total proportion of nontun-
neled CVCs inserted into the femoral vein decreased from
12.9% before the intervention to 9.4% after the intervention
(relative ratio, 0.73; 95% CI, 0.61-0.88) (Table 2). Of the 4821
observed nontunneled and tunneled CVCs, 1108 (23%) had
visible blood either on or under the insertion site dressing.
The total proportion of CVCs with visible blood at the in-
sertion site did not change significantly from the preinter-
vention period to the postintervention period (relative ratio,
0.90; 95% CI, 0.81-1.00) (Table 2). Finally, for 1528 (31.7%)
of CVC dressings, the date that they were last changed was
recorded. The total proportion of dated dressings increased
from 26.6% before the intervention to 34.4% after the in-
tervention (relative ratio, 1.29; 95% CI, 1.17-1.42) (Table 2).
During the study, 737 CA-BSIs occurred. Three units (units
A, B, and F) had significant decreases in CA-BSI rates after
the intervention. The overall rate of CA-BSI significantly de-
creased from the preintervention period to the postinterven-
tion period (11.2 vs. 8.9 cases per 1,000 CVC-days; rate ratio,
0.79; 95% CI, 0.67-0.93) (Table 3). Exclusion of data from
the unit that had an earlier intervention separate from the
study intervention resulted in a slight reduction in the overall
postintervention infection rate (rate ratio, 0.73; 95% CI, 0.62-
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figure 1. Overall incidence of catheter-associated bloodstream infection (CA-BSI) during the preintervention period and postinter-
vention periods for 13 units at 6 hospitals. Whiskers, 95% confidence interval estimate. ∗ versus the preintervention period.P ! .05
figure 2. Correlation of the relative ratio for use of femoral
vein central venous catheter (CVC) insertion site and the relative
rate of catheter-associated bloodstream infection (CA-BSI) before
and after the intervention. Data for units with undefined relative
ratios for use of the femoral catheter insertion site (units I and M)
are not shown.
0.87). The overall CA-BSI rate was lowest in the period 7-12
months after the start of the intervention (Figure 1).
The change in the observed proportion of CVCs that were
place in the femoral vein correlated most closely with the
overall change in the CA-BSI rate ( ; ;2rp 0.93 r p 0.86
, by 2-tailed Pearson correlation) (Figure 2). TheP ! .001
change in the CA-BSI rate was not correlated with changes
in the proportion of dated insertion site dressings or visibly
bloody dressings, with the proportion of nurses or physicians
who completed the self-study module, or with investigator-
perceived degree of support for the intervention among unit
personnel (data not shown).
discussion
CA-BSIs are preventable; however, many of the prevention
methods described in the literature rely on technological ad-
vance, rather than ensuring that proper techniques are used.
The multifaceted, education-based intervention we describe,
implemented in 13 units at 6 hospitals, decreased the overall
incidence of CA-BSIs by 21%. The decrease in the infection
rate persisted throughout the 18-month postintervention pe-
riod. The intervention resulted in changes in CVC insertion
practices in the study units; from the preintervention to the
postintervention period, there was a 27% reduction in the
prevalence of nontunneled CVCs inserted in the femoral vein
and a 29% increase in the proportion of catheter dressing
sites that had that date of last dressing change clearly marked.
Among individual units, the intervention had variable effects.
The efficacy of the intervention correlated most closely with
changes in the insertion sites for nontunneled CVCs.
To our knowledge, this is the first multiple-center, edu-
cation-based intervention to prevent CA-BSI among patients
at acute care facilities. The reduction in CA-BSI rates in our
study reached a maximum approximately 7-12 months after
the start of the intervention. The delay might have been a
function of the time required to change nurses’ and physi-
cians’ actual practices, rather than the time required to change
the policies. The change in CVC insertion and care practice
that best correlated with a reduction in the infection rate was
the degree to which an individual unit reduced the proportion
of nontunneled catheters inserted in the femoral vein. Pre-
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vious studies have noted that CVCs inserted in the femoral
vein are associated with a higher risk of subsequent CA-BSIs
and venous thrombosis than are CVCs placed in the subcla-
vian vein or internal jugular vein.10,11,27 However, because of
the multifaceted nature of this study, it cannot be concluded
that this single change in practice reduced infection rates. It
is possible that changes in this insertion practice may have
been a surrogate for other improvements in catheter insertion
practices (eg, use of maximal sterile barrier precautions) and/
or for the level of support for the intervention by physician
leadership in each unit.
Although insertion site dressing care did improve, as mea-
sured by the proportion of dressings properly dated, the over-
all rate of dating remained low (34%). In one unit (unit I),
no dressing sites were dated before or after the intervention.
This unit had a policy of routine daily gauze dressing changes
before the start of the intervention and did not change this
policy. The proportion of visibly bloody dressings significantly
decreased in 3 individual units but not overall. The percentage
of visibly bloody dressings at baseline in this study was highly
variable (3%–65%), which might have been more a function
of the patient populations in the individual units (eg, cardiac
patients receiving anticoagulants) than a function of nurs-
ing care. Previous studies have shown that the local opinion
leaders can affect the success or failure of behavior-based
interventions.28,29 However, we did not find a correlation be-
tween the investigators’ perception of how strongly the med-
ical and nursing staff supported the intervention and the
postintervention infection rate. We do not know whether the
level of support from the leadership truly did not affect the
outcome of the study or whether the method we used to
assess leaders’ support was too imprecise.
Although there was an overall decrease in CA-BSI rates,
there was variability in the impact of the intervention among
the various units. Three units (units E, I, and J) had non-
significant increases in the rate of infection. All 3 of these
units had increases in the proportion of CVCs placed in the
femoral vein, 2 had an increase or no change in the pro-
portion of visibly bloody dressings, and all 3 had no change
in the proportion of dated dressings from the preintervention
period to the postintervention period. There are several pos-
sible explanations for these observations. Despite a relatively
high level of perceived support by investigators in one unit
(unit E), it may have been possible that the intervention was
not accepted and implemented as completely in these units.
Because resources were limited, some processes of care were
not measured, such as use of maximal sterile barrier precau-
tions during catheter insertion and use of sterile technique
during dressing changes, which might have correlated more
closely with changes in infection rates. The variability in the
effect of this intervention among the 13 units in this study
highlights the complexity of implementing education-based
interventions at multiple centers.
The use of a preintervention-postintervention design is a
potential limitation of this study. Unmeasured changes in
patient and unit characteristics could have occurred during
the study that might account for the decrease in CA-BSI rates.
Although we cannot completely exclude the possibility that
unanticipated changes occurred in the study units, local in-
vestigators consulted with unit and infection control staff to
assess other obvious confounders, such as the earlier inter-
vention performed in one of the study units. No other in-
terventions or significant changes were identified. In addition,
no units introduced the use of antimicrobial-impregnated
catheters, other than the 5 units that were already using them
at the start of the study. Moreover, to ensure that staff mem-
bers at each site accepted the intervention, we allowed in-
vestigators at each site to vary the intervention somewhat to
fit the needs of their site. Thus, although changes in choice
of catheter insertion site correlated best with changes in the
infection rate, we cannot determine from our results whether
the decrease in the infection rate was the result of all the
changes in aggregate or whether a single aspect of the inter-
vention was the critical component.
The overall effect of this intervention in reducing CA-BSI
rates in these units was substantial. On the basis of data in
the literature, we estimated that because approximately 131
infections were prevented among the 13 study units in the
postintervention period, 13 deaths attributable to CA-BSI
were averted,30 260-286 days of hospitalization were avoided,31
and $3,111,381 to $4,358,108 in excess hospital costs were
saved.32,33 This study demonstrates that an education-based
intervention can be successfully implemented in a diverse set
of medical and surgical units and can reduce CA-BSI rates
over a prolonged period.
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